In short
Capecitabine is an oral chemotherapy drug being studied in various clinical trials for different types of cancer. These trials aim to evaluate its effectiveness, safety, and optimal dosing when used alone or in combination with other treatments. The research focuses on cancers such as rectal, gastric, biliary tract, and breast cancer, exploring capecitabine's potential in neoadjuvant, adjuvant, and metastatic settings.
At a glance
- Cancer Types Studied
- Rectal cancer, gastric cancer, biliary tract cancer, triple-negative breast cancer
- Treatment Settings
- Neoadjuvant (before surgery), adjuvant (after surgery), metastatic disease
- Combination Therapies
- Radiotherapy, other chemotherapy drugs (e.g., gemcitabine, oxaliplatin), targeted therapies (e.g., bevacizumab, trastuzumab)
- Dosing Strategies
- Standard dosing (e.g., 1000-1650 mg/m2/day), metronomic dosing (e.g., 650 mg/m2 twice daily for 1 year)
- Primary Outcomes
- Progression-free survival, pathological complete response, disease-free survival
- Secondary Outcomes
- Overall survival, tumor response rate, toxicity profile, quality of life
- Patient Populations
- Various age groups, including elderly patients (over 70 years old in some studies)
- Trial Phases
- Phase I, II, and III studies represented
What is Capecitabine?
Capecitabine, also known by its brand names Xeloda or Xeloda, is an oral medication used in cancer treatment. It belongs to a class of drugs called fluoropyrimidine carbamates, which are designed to interfere with cancer cell growth. Capecitabine is what's known as a prodrug, which means it's inactive when you take it, but your body converts it into an active form of the medication called fluorouracil (5-FU) once it reaches the tumor site.
What Conditions Does Capecitabine Treat?
Capecitabine is used to treat several types of cancer, including:
- Colorectal Cancer: Including metastatic colorectal cancer (cancer that has spread to other parts of the body)
- Breast Cancer: Particularly HER2+ metastatic breast cancer
- Gastric (Stomach) Cancer: Including advanced and metastatic forms
- Gastroesophageal Junction Adenocarcinoma: Cancer that occurs where the esophagus meets the stomach
- Anal Canal Cancer: Used in combination with other treatments
How Does Capecitabine Work?
Capecitabine works by interfering with the DNA production of cancer cells. When you take the medication, your body converts it into 5-FU at the tumor site. This active form of the drug then blocks an enzyme called thymidylate synthase, which is necessary for DNA replication. By doing this, capecitabine stops cancer cells from dividing and growing.
In some treatment regimens, capecitabine is used in a "metronomic" approach. This means it's given in lower doses but more frequently, which may help to prevent the growth of blood vessels that feed tumors (a process called angiogenesis).
How is Capecitabine Administered?
Capecitabine is taken orally in the form of tablets. The dosage and schedule can vary depending on the specific treatment plan, but some common approaches include:
- Twice daily dosing, often for 14 days followed by a 7-day rest period
- Continuous daily dosing in some metronomic regimens
- Dosages are typically calculated based on body surface area (BSA)
It's important to take capecitabine exactly as prescribed by your doctor. The tablets should be swallowed whole with water within 30 minutes after a meal.
Capecitabine in Combination Therapies
Capecitabine is often used in combination with other cancer treatments to enhance its effectiveness. Some common combinations include:
- Capecitabine + Docetaxel: Used in treating advanced gastric cancer
- Capecitabine + Oxaliplatin + Irinotecan + Bevacizumab: Used in treating colorectal cancer liver metastases
- Capecitabine + Mitomycin + Panitumumab: Used with radiation therapy in treating anal canal cancer
- Capecitabine + Neratinib or Lapatinib: Used in treating HER2+ metastatic breast cancer
Potential Side Effects
Like all medications, capecitabine can cause side effects. Some common side effects may include:
- Diarrhea
- Nausea and vomiting
- Hand-foot syndrome (redness, swelling, and pain on the palms of hands and soles of feet)
- Fatigue
- Loss of appetite
Your healthcare team will monitor you closely for these and other potential side effects. It's important to report any new symptoms or changes in your health to your doctor promptly.
Ongoing Research and Clinical Trials
Researchers continue to study capecitabine to find new ways to use it effectively. Some areas of ongoing research include:
- Using capecitabine in combination with immunotherapy drugs like avelumab for treating rectal cancer
- Exploring metronomic dosing of capecitabine in various cancer types
- Investigating capecitabine as part of perioperative treatment (treatment given before and after surgery) for colorectal cancer liver metastases
- Studying capecitabine in combination with newer targeted therapies for breast cancer
These ongoing studies aim to improve the effectiveness of capecitabine and expand its use to benefit more patients with various types of cancer.